glp-1 retatrutide and LDL Cholesterol: How Medications Lower Heart Dis – Revolution Health & Wellness A review of an investigational

Glucagon-like peptide-1 gastrointestinal regulatory role in metabolism and motility

[DOI] [PubMed] [Google Scholar] 12.Wei Y., Lin F.J., Lin S.Y., Wang C.C

Common Side Effects and Safety Considerations Gastrointestinal side effects are the most frequently reported adverse reactions with GLP-1 receptor agonists, affecting a substantial proportion of patients, particularly during treatment initiation

Even 12 glasses of wine nightly: slows fat oxidation liver prioritizes alcohol metabolism temporarily halts fat burning increases triglyceride production GLP-1 users already eat less but alcohol can: reduce lean mass retention slow metabolic adaptation increase visceral fat storage So the scale may still drop but body composition worsens

There is evidence from a large dataset of human clinical trials for fiber supplementation reducing constipation [93]